loadpatents
name:-0.15733003616333
name:-0.13714504241943
name:-0.00066494941711426
Allergan Sales, Inc. Patent Filings

Allergan Sales, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Allergan Sales, Inc..The latest application filed is for "activatable recombinant neurotoxins".

Company Profile
0.128.112
  • Allergan Sales, Inc. -
  • Allergan Sales, Inc. - Irvine CA
  • Allergan Sales, Inc - Irvine CA
  • Allergan Sales, Inc - 2525 Dupont Irvine CA
  • Allergan Sales, Inc. - 2525 Dupont Drive Irvine CA
  • Allergan Sales, Inc. - 2525 Dupont Irvine CA
  • Allergan Sales, Inc. - N/A
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Activatable Recombinant Neurotoxins
App 20070259401 - Dolly; J. Oliver ;   et al.
2007-11-08
GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
App 20060154314 - Steward; Lance E. ;   et al.
2006-07-13
Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins
App 20050260230 - Steward, Lance E. ;   et al.
2005-11-24
Calcium blockers to treat proliferative vitreoretinopathy
App 20050192322 - Dreyer, Evan B.
2005-09-01
GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
App 20050100973 - Steward, Lance E. ;   et al.
2005-05-12
Pain treatment by peripheral administration of a neurotoxin
Grant 6,869,610 - Aoki , et al. March 22, 2
2005-03-22
Thromboxane ligands without blood clotting side effects
App 20050049300 - Burk, Robert M. ;   et al.
2005-03-03
Nuclei density and nuclei area methods for determining effects of a botulinum toxin on muscles
App 20050019338 - Holland, James M. ;   et al.
2005-01-27
Preserved cyclodextrin-containing compositions
App 20040175435 - Beck, Gary J. ;   et al.
2004-09-09
Agents and methods for treating pain
App 20040146532 - Gil, Daniel W. ;   et al.
2004-07-29
Ophthalmic compositions of lubricating eyes and methods for making and using same
App 20040005289 - Chang, James N. ;   et al.
2004-01-08
Stable RXR expressing cell line
App 20030228632 - Kusari, Jyotirmoy ;   et al.
2003-12-11
Clostridial neurotoxin compositions and modified clostridial neurotoxins
App 20030219462 - Steward, Lance E. ;   et al.
2003-11-27
Intraocular lens insertion apparatus
App 20030216745 - Brady, Daniel G. ;   et al.
2003-11-20
Therapeutic treatments for neuropsychiatric disorders
App 20030211121 - Donovan, Stephen
2003-11-13
Method for treating tardive dyskinesia with Botulinum toxin type B
Grant 6,645,496 - Aoki , et al. November 11, 2
2003-11-11
Compositions containing alpha-2-adrenergic agonist components
Grant 6,641,834 - Olejnik , et al. November 4, 2
2003-11-04
Compositions for treating hyperemia
App 20030203034 - Huth, Stanley W.
2003-10-30
Method of improving adherence and centering of intra-corneal implants on corneal bed
App 20030204252 - Paul, Marlene L. ;   et al.
2003-10-30
Intraocular lens insertion apparatus
App 20030195522 - McNicholas, Thomas M. ;   et al.
2003-10-16
Conformationally rigid bicyclic and adamantane derivatives useful as alpha2-adrenergic blocking agents
App 20030187047 - Munk, Stephen A. ;   et al.
2003-10-02
Methods for treating cardiovasular diseases with botulinum toxin
App 20030185860 - Brooks, Gregory F.
2003-10-02
Method for determining effect of a clostridial toxin upon a muscle
App 20030178029 - Hanin, Lisa D.
2003-09-25
Foldable intraocular lenses with highly flexible optic and rigid fixation members
App 20030181977 - Brady, Daniel G.
2003-09-25
Photodynamic therapy for pre-melanomas
App 20030176411 - Voet, Martin A.
2003-09-18
IOL insertion apparatus and method for using same
App 20030176870 - Ott, Robert D.
2003-09-18
Apparatus For Protecting The Edge Geometry Of An Intraocular Lens During Glass Bead Polishing Process
App 20030176918 - Schneider, Ned E.
2003-09-18
Methods for treating inflammation pain
App 20030165541 - Donovan, Stephen
2003-09-04
Compositions containing therapeutically active components having enhanced solubility
App 20030153530 - Olejnik, Orest ;   et al.
2003-08-14
Composition and method for modulating BAR/FXR receptor activity
App 20030144360 - Forman, Barry M. ;   et al.
2003-07-31
3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
App 20030144254 - Burk, Robert M. ;   et al.
2003-07-31
Male anti-fertility agents
App 20030144256 - Klein, Elliott S. ;   et al.
2003-07-31
Binocular lens systems
App 20030125806 - Lang, Alan J.
2003-07-03
Compositions including antibiotics and methods for using same
App 20030114464 - Muller, Christopher A. ;   et al.
2003-06-19
Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
App 20030114460 - Hughes, Patrick M. ;   et al.
2003-06-19
Methods for measuring retinal damage
App 20030114772 - David, Robert ;   et al.
2003-06-19
Accommodating intraocular lens
App 20030109925 - Ghazizadeh, Massoud ;   et al.
2003-06-12
Thromboxane ligands without blood clotting side effects
App 20030109571 - Burk, Robert M. ;   et al.
2003-06-12
Prostanoic acid derivatives as agents for lowering intraocular pressure
App 20030105155 - Burk, Robert M. ;   et al.
2003-06-05
Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
App 20030092612 - Lyons, Robert T.
2003-05-15
Compositions containing alpha-2-adrenergic agonist components
App 20030087893 - Olejnik, Orest ;   et al.
2003-05-08
Methods and compositions for the treatment and prevention of lung disease
App 20030078294 - Chandraratna, Roshantha A. ;   et al.
2003-04-24
Antibiotic compositions and methods for using same
App 20030073694 - Muller, Christopher A. ;   et al.
2003-04-17
Compositions including vitamin-based surfactants and methods for using same
App 20030068250 - Huth, Stanley ;   et al.
2003-04-10
Methods and compositions for modulating alpha adrenergic receptor activity
Grant 6,545,182 - Chow , et al. April 8, 2
2003-04-08
IOL for inhibiting cell growth and reducing glare
App 20030060879 - Paul, Marlene L. ;   et al.
2003-03-27
Calcium blockers to treat proliferative vitreoretinopathy
App 20030060510 - Dreyer, Evan B.
2003-03-27
Methods for treating fibromyalgia
App 20030054975 - Voet, Martin A.
2003-03-20
IOL for inhibiting cell growth and reducing glare
App 20030055498 - Paul, Marlene L. ;   et al.
2003-03-20
Methods of treatment with compounds having RAR.alpha. receptor specific or selective activity
Grant 6,534,544 - Teng , et al. March 18, 2
2003-03-18
Stepped IOL insertion cartridge inserting an intraocular lens in an eye
App 20030050647 - Brady, Daniel G.
2003-03-13
Anterior chamber intraocular lens and methods for reducing pupil ovalling
App 20030050697 - Paul, Marlene L.
2003-03-13
Iris-supported intraocular lenses
App 20030045932 - Brady, Daniel G.
2003-03-06
Apparatus and methods for packaging intrcorneal implants and facilitating placement thereof
App 20030045930 - Nguyen, Tuyet Hoc
2003-03-06
Ophthalmic lens systems
App 20030045931 - Lang, Alan J.
2003-03-06
Foldable intraocular lenses with highly flexible optics and rigid fixation members
App 20030045933 - Brady, Daniel G.
2003-03-06
Method for treating thyroid disorders
Grant 6,524,580 - Donovan February 25, 2
2003-02-25
Anterior chamber intraocular lens having fixation members attached to the cornea and methods of implantation
App 20030033014 - Gwon, Arlene ;   et al.
2003-02-13
Compositions containing alpha-2-adrenergic agonist components
App 20030027811 - Olejnik, Orest ;   et al.
2003-02-06
Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
App 20030027846 - Old, David W. ;   et al.
2003-02-06
Leucine-based motif and clostridial neurotoxins
App 20030027752 - Steward, Lance E. ;   et al.
2003-02-06
3, 7or3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
App 20030027853 - Burk, Robert M. ;   et al.
2003-02-06
Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
App 20030023098 - Chow, Ken ;   et al.
2003-01-30
Glaucoma treatments with reduced hyperpigmentation
App 20030018078 - Woodward, David F. ;   et al.
2003-01-23
Anterior chamber angle-supported intraocular lenses with flexible optic and rigid fixation members
App 20030018386 - Laguette, Stephen W. ;   et al.
2003-01-23
Biodegradable botulinum toxin implant
Grant 6,506,399 - Donovan January 14, 2
2003-01-14
Disinfecting and solubilizing steroid compositions
App 20020198174 - Lyons, Robert T.
2002-12-26
Compositions having enhanced pharmacokinetic characteristics
App 20020198209 - Woodward, David F. ;   et al.
2002-12-26
Alpha-2-adrenergic Agonist/fatty Acid Compositions
App 20020198210 - Woodward, David F. ;   et al.
2002-12-26
Therapy for injured muscles
App 20020192240 - Brooks, Gregory F. ;   et al.
2002-12-19
Lactam compounds for penetration enhancement
App 20020193449 - Ewing, Gary
2002-12-19
Intraocular lens implanting instrument
App 20020193803 - Portney, Valdemar
2002-12-19
Methods of treating hyperlipidemia
App 20020193403 - Yuan, Yang-Dar ;   et al.
2002-12-19
IOL insertion apparatus with IOL engagement structure and method for using same
App 20020193805 - Ott, Robert D. ;   et al.
2002-12-19
Monofocal intraocular lens convertible to multifocal intraocular lens
App 20020188351 - Laguette, Stephen W.
2002-12-12
Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
App 20020183328 - Wheeler, Larry A. ;   et al.
2002-12-05
Pain treatment by peripheral administration of a neurotoxin
App 20020176872 - Aoki, Kei Roger ;   et al.
2002-11-28
Compositions and methods for treating gonadotrophin related illnesses
App 20020177545 - Donovan, Stephen
2002-11-28
Prostanoic acid derivatives as agents for lowering intraocular pressure
App 20020177620 - Burk, Robert M. ;   et al.
2002-11-28
Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists
App 20020165399 - Burk, Robert M. ;   et al.
2002-11-07
(2-hydroxy)ethyl-thioureas useful as modulators of alpha2B adrenergic receptors
App 20020161051 - Chow, Ken ;   et al.
2002-10-31
Moveable intraocular lens
App 20020161434 - Laguette, Stephen W. ;   et al.
2002-10-31
Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B / 2C adrenergic receptors
App 20020156076 - Chow, Ken ;   et al.
2002-10-24
Binocular lens systems
App 20020143394 - Lang, Alan J.
2002-10-03
Method for treating hypercalcemia
Grant 6,447,785 - Donovan September 10, 2
2002-09-10
Apparatus for holding intraocular lenses and injectors, and methods for using same
Grant 6,447,519 - Brady , et al. September 10, 2
2002-09-10
Scleral implants for treating presbyopia and methods for implanting the same
App 20020123804 - Gwon, Arlene ;   et al.
2002-09-05
Moveable intraocular lenses and combinations of intraocular lenses
App 20020120329 - Lang, Alan J. ;   et al.
2002-08-29
Pharmaceutical compositions containing buffered ortho ester polymers
Grant 6,440,460 - Gurny , et al. August 27, 2
2002-08-27
Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
App 20020111357 - Wheeler, Larry A. ;   et al.
2002-08-15
Methods of administering botulinum toxin
App 20020107199 - Walker, Patricia S.
2002-08-08
Intraocular lens implanting instrument
Grant 6,428,545 - Portney August 6, 2
2002-08-06
Methods and compositions for the treatment of cerebral palsy
App 20020102275 - Graham, Herbert Kerr
2002-08-01
Apparatus And Method For Multiply Folding And Inserting An Intraocular Lens In An Eye
App 20020103490 - Brady, Daniel G.
2002-08-01
Stepped IOL insertion cartridge inserting an intraocular lens in an eye
App 20020103491 - Brady, Daniel G.
2002-08-01
Clostridial toxin therapy for Hashimoto's thyroiditis
App 20020102274 - Voet, Martin A. ;   et al.
2002-08-01
Neurotoxin implant
App 20020098237 - Donovan, Stephen ;   et al.
2002-07-25
Methods for treating muscle injuries
Grant 6,423,319 - Brooks , et al. July 23, 2
2002-07-23
Flexible irrigation/aspiration tip assembly for providing irrigation to an eye capsule and for aspirating fluid from the eye capsule
Grant 6,423,074 - Chen July 23, 2
2002-07-23
Methods for treating mammary gland disorders
App 20020094339 - Brin, Mitchell F. ;   et al.
2002-07-18
Methods for treating hyperhidrosis
App 20020086036 - Walker, Patricia S.
2002-07-04
Cyclopentane(ENE)heptenoic or heptenoic acids and derivatives thereof useful as therapeutic agents
Grant 6,414,022 - Burk July 2, 2
2002-07-02
2,4-pentadienoic acid derivatives having retinoid-like biological activity
App 20020082419 - Vuligonda, Vidyasagar ;   et al.
2002-06-27
Method for treating a mucus secretion
App 20020082197 - Aoki, Kei Roger ;   et al.
2002-06-27
3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
Grant 6,410,591 - Burk , et al. June 25, 2
2002-06-25
Cholinergic agents in the treatment of presbyopia
Grant 6,410,544 - Gwon , et al. June 25, 2
2002-06-25
Methods of treatment with compounds having RAR alpha receptor specific or selective activity
App 20020077360 - Teng, Min ;   et al.
2002-06-20
Preserved cyclodextrin-containing compositions
App 20020076449 - Beck, Gary J. ;   et al.
2002-06-20
Moveable intraocular lens
Grant 6,406,494 - Laguette , et al. June 18, 2
2002-06-18
Compositions containing therapeutically active components having enhanced solubility
App 20020071874 - Olejnik, Orest ;   et al.
2002-06-13
Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents
Grant 6,403,649 - Woodward , et al. June 11, 2
2002-06-11
2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
Grant 6,403,638 - Vuligonda , et al. June 11, 2
2002-06-11
Clostridial toxin derivatives and methods for treating pain
App 20020068699 - Donovan, Stephen
2002-06-06
Methods of treating animals with botulinum toxin pharmaceutical compositions
App 20020064536 - Hunt, Terrence J.
2002-05-30
Power mode phaco
Grant 6,394,974 - Kadziauskas , et al. May 28, 2
2002-05-28
Cyclopentane Heptan(ene)oic Acid, 2-thiocarbamoyloxy And 2-carbamoyloxy Compounds As Therapeutic Agents
App 20020058692 - Burk, Robert M.
2002-05-16
Methods and compositions for modulating alpha adrenergic receptor activity
App 20020058839 - Chow, Ken ;   et al.
2002-05-16
Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
Grant 6,387,892 - Vasudevan , et al. May 14, 2
2002-05-14
Treatment of tumors with RAR.alpha. selective retinoid compounds in combination with other anti-tumor agents
Grant 6,387,950 - Nehme , et al. May 14, 2
2002-05-14
Biodegradable neurotoxin implant
Grant 6,383,509 - Donovan , et al. May 7, 2
2002-05-07
Compounds having activity as inhibitors of cytochrome P450RAI
Grant 6,380,256 - Vasudevan , et al. April 30, 2
2002-04-30
Conformationally rigid bicyclic and adamantane derivatives useful as alpha2-adrenergic blocking agents
App 20020049241 - Munk, Stephen A. ;   et al.
2002-04-25
Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
Grant 6,376,533 - Burk , et al. April 23, 2
2002-04-23
Intraspinal botulinum toxin for treating pain
Grant 6,372,226 - Aoki , et al. April 16, 2
2002-04-16
Compounds having activity as inhibitors of cytochrome P450RAI
Grant 6,369,261 - Johnson , et al. April 9, 2
2002-04-09
Compounds having activity as inhibitors of cytochrome P450RAI
Grant 6,369,225 - Vasudevan , et al. April 9, 2
2002-04-09
Clostridial toxin derivatives and methods for treating pain
App 20020037833 - Donovan, Stephen
2002-03-28
Dual position foot pedal for ophthalmic surgery apparatus
Grant 6,360,630 - Holtorf March 26, 2
2002-03-26
Preserved cyclodextrin-containing compositions
Grant 6,358,935 - Beck , et al. March 19, 2
2002-03-19
Method for treating Hashimoto's thyroiditis
Grant 6,358,513 - Voet , et al. March 19, 2
2002-03-19
Neurotoxin therapy for inner ear disorders
Grant 6,358,926 - Donovan March 19, 2
2002-03-19
Compositions containing alpha-2-adrenergic agonist components
App 20020032201 - Olejnik, Orest ;   et al.
2002-03-14
Method for treating a catecholamine secretion
Grant 6,350,455 - Donovan February 26, 2
2002-02-26
Ocular treatment using cyclosporin-A derivatives
Grant 6,350,442 - Garst February 26, 2
2002-02-26
Apparatus for holding contact lens care composition and contact lens case
App 20020020437 - Vanden Dries, John W. ;   et al.
2002-02-21
Method for treating parathyroid disorders
App 20020018786 - Donovan, Stephen
2002-02-14
Multifocal phakic intraocular lens
App 20020016630 - Lang, Alan J.
2002-02-07
O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
Grant 6,344,561 - Vuligonda , et al. February 5, 2
2002-02-05
Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thichroman and 1,2,3,4-tetrahydroquinolinecarboxlic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
Grant 6,342,602 - Teng , et al. January 29, 2
2002-01-29
Combinations of prostaglandins and brimonidine or derivatives thereof
App 20020010202 - Garst, Michael E.
2002-01-24
Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
App 20020002150 - Burk, Robert M.
2002-01-03
Methods of treating pain and other conditions
Grant 6,329,369 - Chow , et al. December 11, 2
2001-12-11
Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
App 20010046998 - Wheeler, Larry A. ;   et al.
2001-11-29
Intraocular lens implanting instrument
App 20010044628 - Portney, Valdemar
2001-11-22
Method for treating dystonia with botulinum toxin types C to G
Grant 6,319,505 - Aoki , et al. November 20, 2
2001-11-20
Treatment of tumors with RARalpha selective retinoid compounds in combination with other anti-tumor agents
App 20010039293 - Nehme, Alissar ;   et al.
2001-11-08
Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies
Grant 6,313,168 - Pacifici , et al. November 6, 2
2001-11-06
Botulinum toxin implant
Grant 6,312,708 - Donovan November 6, 2
2001-11-06
Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
Grant 6,313,107 - Vasudevan , et al. November 6, 2
2001-11-06
Methods for reducing non-inflammatory pain
App 20010034353 - Cheetham, Janet K. ;   et al.
2001-10-25
Implant device with a retinoid for improved biocompatibility
Grant 6,306,426 - Olejnik , et al. October 23, 2
2001-10-23
Method for treating parkinson's disease with a botulinum toxin
Grant 6,306,403 - Donovan October 23, 2
2001-10-23
Neurotoxin implant
Grant 6,306,423 - Donovan , et al. October 23, 2
2001-10-23
Compounds having activity as inhibitors of cytochrome P450RAI
Grant 6,303,785 - Vasudevan , et al. October 16, 2
2001-10-16
Method for treating ocular pain
Grant 6,294,553 - Gil , et al. September 25, 2
2001-09-25
Combinations of prostaglandins and brimonidine or derivatives thereof
Grant 6,294,563 - Garst September 25, 2
2001-09-25
Method for treating parathyroid disorders
App 20010023243 - Donovan, Stephen
2001-09-20
Apparatus for holding contact lens care composition and contact lens case
Grant 6,289,906 - Vanden Dries , et al. September 18, 2
2001-09-18
Cholinergic agents in the treatment of presbyopia
Grant 6,291,466 - Gwon , et al. September 18, 2
2001-09-18
Screen navigation control apparatus for ophthalmic surgical instruments
Grant 6,292,178 - Bernstein , et al. September 18, 2
2001-09-18
Compounds having activity as inhibitors of cytochrome P450RAI
Grant 6,291,677 - Vasudevan , et al. September 18, 2
2001-09-18
IOL insertion apparatus and method for making and using same
Grant 6,283,975 - Glick , et al. September 4, 2
2001-09-04
Intraocular lens implanting instrument
Grant 6,283,976 - Portney September 4, 2
2001-09-04
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
App 20010016597 - Burk, Robert M.
2001-08-23
Anti-angiogenic agents
Grant 6,271,220 - Garst , et al. August 7, 2
2001-08-07
Method for treating otic disorders
Grant 6,265,379 - Donovan July 24, 2
2001-07-24
Self instill push housing eye drop dispenser
Grant D445,177 - Cogger July 17, 2
2001-07-17
Method for treating a pancreatic disorder with a neurotoxin
Grant 6,261,572 - Donovan July 17, 2
2001-07-17
Thermal mode phaco apparatus and method
Grant 6,261,297 - Kadziauskas , et al. July 17, 2
2001-07-17
Dual position foot pedal for ophthalmic surgery apparatus
Grant 6,260,434 - Holtorf July 17, 2
2001-07-17
Self instill push housing eye drop dispenser with cap
Grant D445,178 - Cogger July 17, 2
2001-07-17
Cyclopentane (ene) oic acid, 2-alkenyl derivatives as therapeutic agents
Grant 6,258,844 - Garst , et al. July 10, 2
2001-07-10
Stable gel formulation for topical treatment of skin conditions
Grant 6,258,830 - Charu July 10, 2
2001-07-10
Method for delivering viscoelastic material to an eye
Grant 6,254,587 - Christ , et al. July 3, 2
2001-07-03
Ocular treatment using cyclosporin-A derivatives
Grant 6,254,860 - Garst July 3, 2
2001-07-03
Multiple precision dose, preservative-free medication delivery system
Grant 6,254,579 - Cogger , et al.
2001-07-03
Intraocular lenses made from polymeric compositions
App 20010005743 - Liao, Xiugao ;   et al.
2001-06-28
Compounds having activity as inhibitors of cytochrome P450RAI
Grant 6,252,090 - Vasudevan , et al. June 26, 2
2001-06-26
Rotatable IOL insertion apparatus and method for using same
Grant 6,251,114 - Farmer , et al. June 26, 2
2001-06-26
IOL insertion apparatus and methods for using same
Grant 6,248,111 - Glick , et al. June 19, 2
2001-06-19
Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
Grant 6,248,741 - Wheeler , et al. June 19, 2
2001-06-19
Intraocular lenses made from polymeric compositions and monomers useful in said compositions
Grant 6,245,106 - Makker , et al. June 12, 2
2001-06-12
Posterior/anterior chamber intraocular lenses and methods of implantation
Grant 6,238,433 - Portney May 29, 2
2001-05-29
Intraspinal methods for treating pain
Grant 6,235,289 - Aoki , et al. May 22, 2
2001-05-22
Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
Grant 6,235,923 - Song , et al. May 22, 2
2001-05-22
Accommodating multifocal intraocular lens
Grant 6,231,603 - Lang , et al. May 15, 2
2001-05-15
Trisubstituted phenyl derivatives having retinoid agonist or inverse agonist type biological activity
Grant 6,225,494 - Song , et al. May 1, 2
2001-05-01
Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
Grant 6,218,128 - Klein , et al. April 17, 2
2001-04-17
Process for preparing substituted benzo[1,2-G]-chrome-3-ene, benzo[1,2-G]-thiochrom-3-ene and benzo[1,2-G]-1,2-dihydroquinoline derivatives
Grant 6,211,385 - Vuligonda , et al. April 3, 2
2001-04-03
Modification of clostridial toxins for use as transport proteins
Grant 6,203,794 - Dolly , et al. March 20, 2
2001-03-20
Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury
Grant 6,194,415 - Wheeler , et al. February 27, 2
2001-02-27
O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
Grant 6,187,933 - Vuligonda , et al. February 13, 2
2001-02-13
Accommodating intraocular lens
Grant 6,176,878 - Gwon , et al. January 23, 2
2001-01-23
Methods for restoring and/or enhancing accommodation in pseudo phakia
Grant 6,164,282 - Gwon , et al. December 26, 2
2000-12-26
Antibiotic compositions and method for using same
Grant 6,166,012 - Muller , et al. December 26, 2
2000-12-26
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
Grant 6,160,129 - Burk December 12, 2
2000-12-12
Intraocular lens injector holder
Grant D434,558 - Brady , et al. December 5, 2
2000-12-05
2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
Grant 6,147,224 - Vuligonda , et al. November 14, 2
2000-11-14
Methods for treating pancreatic disorders
Grant 6,143,306 - Donovan November 7, 2
2000-11-07
Method for treating cancer with a neurotoxin
Grant 6,139,845 - Donovan October 31, 2
2000-10-31
Apparatus for holding intraocular lenses and injectors, and methods for using same
Grant 6,129,733 - Brady , et al. October 10, 2
2000-10-10
Amines substituted with a tetrahydroquinolinyl group an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
Grant 6,127,382 - Beard , et al. October 3, 2
2000-10-03
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
Grant 6,124,344 - Burk September 26, 2
2000-09-26
Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist like biological activity
Grant 6,117,987 - Johnson , et al. September 12, 2
2000-09-12
Methods for treating pain
Grant 6,113,915 - Aoki , et al. September 5, 2
2000-09-05
2,4-pentadienoic acid derivatives having retinoid-like biological activity
Grant 6,114,533 - Vuligonda , et al. September 5, 2
2000-09-05
Sterile bioerodible implant device with a retinoid for improved biocompatability
Grant 6,110,485 - Olejnik , et al. August 29, 2
2000-08-29
Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
Grant 6,090,826 - Chandraratna July 18, 2
2000-07-18
EP.sub.2 -receptor agonists as neuroprotective agents for the eye
Grant 6,090,847 - Woodward July 18, 2
2000-07-18
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
Grant 6,090,810 - Klein , et al. July 18, 2
2000-07-18
Benzo[1,2-G]-chrom-3-ene, and benzo[1,2-G]-thiochrom-3-ene derivatives
Grant 6,087,505 - Vuligonda , et al. July 11, 2
2000-07-11
Thermal mode phaco apparatus and method
Grant 6,083,193 - Kadziauskas , et al. July 4, 2
2000-07-04
Combined bottle and lens case
Grant D426,953 - Vanden Dries , et al. June 27, 2
2000-06-27
Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (GABA) agonists
Grant 6,077,839 - WoldeMussie , et al. June 20, 2
2000-06-20
Sterile bioerodible occular implant device with a retinoid for improved biocompatability
Grant 6,074,661 - Olejnik , et al. June 13, 2
2000-06-13
Fluid management system with vertex chamber
Grant 6,059,765 - Cole , et al. May 9, 2
2000-05-09
Substituted aryl or heteroarylamides having retinoid-like biological activity
Grant 6,051,713 - Teng , et al. April 18, 2
2000-04-18
O-or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
Grant 6,051,731 - Vuligonda , et al. April 18, 2
2000-04-18
Tetrahdroquinolin-2-one 6 or 7-yl, tetrahdroquinilin-2-thione 6 or 7-yl pentadienoic acid and related derivatives having retinoid-like biological activity
Grant 6,048,873 - Vasudevan , et al. April 11, 2
2000-04-11
Process for preparing substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives
Grant 6,043,381 - Vuligonda , et al. March 28, 2
2000-03-28
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
Grant 6,037,364 - Burk March 14, 2
2000-03-14
Automated phaco pack bar code reader identification
Grant 6,036,458 - Cole , et al. March 14, 2
2000-03-14
Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
Grant 6,037,488 - Song , et al. March 14, 2
2000-03-14
Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid and a PPAR.gamma. ligand
Grant 6,034,110 - Nagpal , et al. March 7, 2
2000-03-07
Wound shaper sleeve
Grant 6,033,376 - Rockley March 7, 2
2000-03-07
2,4-pentadienoic acid derivatives having retinoid-like biological activity
Grant 6,034,242 - Vuligonda , et al. March 7, 2
2000-03-07
Controlled outflow sleeve
Grant 6,013,049 - Rockley , et al. January 11, 2
2000-01-11
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
Grant 6,008,204 - Klein , et al. December 28, 1
1999-12-28
Contact lens disinfecting device and disinfection system
Grant 6,000,534 - Koomruian, Jr. December 14, 1
1999-12-14
Acetylenes disubstituted with a 5 alkyl, aryl or heteroaryl substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
Grant 5,998,471 - Johnson , et al. December 7, 1
1999-12-07
Thin tip phaco needle
Grant 5,993,408 - Zaleski November 30, 1
1999-11-30
Apparatus and method for delivering viscoelastic material to an eye
Grant 5,984,889 - Christ , et al. November 16, 1
1999-11-16
Dual position foot pedal for ophthalmic surgery apparatus
Grant 5,983,749 - Holtorf November 16, 1
1999-11-16
Methods of treatment with compounds having RAR.sub..alpha. receptor specific or selective activity
Grant 5,965,606 - Teng , et al. October 12, 1
1999-10-12
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
Grant 5,958,954 - Klein , et al. September 28, 1
1999-09-28
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
Grant 5,952,345 - Klein , et al. September 14, 1
1999-09-14
Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
Grant 5,919,970 - Song , et al. July 6, 1
1999-07-06
2,4-pentadienoic acid derivatives having retinoid-like biological activity
Grant 5,917,082 - Vuligonda , et al. June 29, 1
1999-06-29
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
Grant 5,877,207 - Klein , et al. March 2, 1
1999-03-02
Polymer, article and method for inhibiting the growth of ocular pathogens in eye care products
Grant 5,854,303 - Powell , et al. December 29, 1
1998-12-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed